Multiple Myeloma /

Round 4: What is the Optimal Immunotherapy for Targeting BCMA?_Krina Patel, MD, MSc and Jonathan Kaufman, MD

27:57

Multiple Myeloma

Multiple Myeloma Similar Videos

Similar Videos

Module 3_BCMA-Targeted Antibody-Drug Conjugates (ADCs)

9:40
Racial Differences in Clinical Trial Participation and Therapeutic Outcomes with a Focus on Multiple Myeloma_Craig Emmitt Cole, MD

51:36
Module 1_Introduction and Rationale for Targeting BCMA on MM Cells

10:45

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611